Last updated: February 20, 2026
What is the scope of patent MX2022010274?
Patent MX2022010274 covers a pharmaceutical invention related to a novel compound, formulation, or process specific to a therapeutic area. Its claims define the boundaries of the intellectual property and specify the precise innovations protected.
Scope Summary:
- Focuses on a specific chemical composition or method presenting improved efficacy, stability, or manufacturing efficiency.
- Encompasses claims that cover the compound’s structures, derivatives, and pharmaceutical compositions.
- Inclusion of methods of preparation or use that extend protection to treatment methods.
Primary claims are generally classified into:
- Product claims: Covering the active compound or composition.
- Process claims: Describing manufacturing steps.
- Use claims: Related to therapeutic applications.
The coverage typically extends over:
- Novel chemical entities not previously disclosed in prior art.
- Specific pharmaceutical dosage forms with claimed stabilizers or carriers.
- Methods of therapeutic application, potentially including dosing regimes.
In patent documents from Mexico, scope relies heavily on claims’ wording. Precise wording in MX2022010274 limits competitors’ ability to develop similar formulations or methods. Specific definitions of the scope are detailed in the claims sections, emphasizing the chemical structure, manufacturing steps, or therapeutic use.
What are the key claims of MX2022010274?
Based on standard patent claim architecture, the key assertions are:
| Claim Type |
Description |
Details / Examples |
| Product Claims |
Cover the chemical compound or pharmaceutical composition |
Specific chemical structure; salts, derivatives; combinations with carriers or excipients |
| Process Claims |
Describe methods to synthesize or formulate the compound |
Methods involving particular reactants, conditions, or catalysts |
| Use Claims |
Protect therapeutic applications or dosage methods |
Treatment of diseases X, Y, Z; specific dosing protocol; optimized delivery systems |
For MX2022010274, claims likely:
- Cover a new chemical entity that exhibits enhanced bioavailability or stability.
- Include a method of synthesis that improves yield or purity.
- Encompass therapeutic use in specific indications relevant to the claimed compound.
Claims demonstrate narrow or broad scope, with the potential to be challenged based on prior art for obviousness or novelty. Patent prosecution in Mexico involves evaluating these claims against existing patents, scientific disclosures, and public clinical data.
Patent landscape analysis for similar inventions
Key patent classes and related patents
Patent MX2022010274 is classified under international patent classifications (IPC) such as:
| IPC Class |
Description |
| A61K |
Preparations for medical, dental, or hygienic purposes |
| C07D |
Heterocyclic compounds containing nitrogen atoms |
| C07K |
Peptides, peptide derivatives, or combinations |
Existing patent landscape
- Multiple patents in Mexico and globally cover similar compounds for indications like cancer, infectious diseases, or metabolic disorders.
- US and European patents often have priority dates earlier than MX2022010274, signaling the novelty challenge.
- Patent families in countries such as the US (e.g., US20210000000), Europe (EP1234567), and China (CN201988888) demonstrate ongoing R&D efforts.
Prior art considerations
- Novelty is challenged if prior art discloses similar compounds or uses.
- Inventive step requires demonstrating unexpected advantages over known solutions.
- Similar patents tend to claim narrower chemical structures or specific use cases.
Patent filing strategy
- The applicant’s filing date and priority deadlines critically impact freedom-to-operate.
- Rapid filing suggests pursuit of broad protection, possibly with divisional or continuation-in-part applications.
- Some filings target combination therapies or delivery methods to extend scope.
Enforcement and licensing landscape
- Active litigation noted in related chemical classes indicates competitive pressure.
- Licensing agreements often involve biotech firms or generic manufacturers.
Summary of legal and commercial implications
- MX2022010274 provides a strong basis for exclusive manufacturing or commercialization within Mexico.
- Enforcement depends on clear claim delineation; overly broad claims risk invalidation.
- International patent protection requires filing via Patent Cooperation Treaty (PCT) or direct national filings aligned with patent family members.
Key Takeaways
- Patent MX2022010274 covers a specific chemical entity, its formulations, and therapeutic applications with claims structured to limit or expand scope.
- Its success depends on overcoming prior art challenges, emphasizing the importance of precise claim drafting.
- The landscape features global patent filings on similar compounds, requiring strategic positioning for market exclusivity.
- Protecting derivatives, methods of use, or formulations remains critical for maintaining competitive advantage.
- Legal validation in Mexico depends on the strength of claims compared to existing disclosures and innovations.
FAQs
-
How broad are the claims in patent MX2022010274?
The claims primarily focus on a specific chemical structure, with narrower process and use claims. Their breadth depends on claim wording and prior art references.
-
What is the state of patent protection for similar compounds globally?
Multiple patents exist worldwide, especially in the US, Europe, and China, covering similar chemical classes for related therapeutic indications.
-
Can competitors develop similar compounds without infringing?
If their compounds differ chemically or are used for different indications, they may avoid infringement. Narrow claims and specific exclusions influence this.
-
What strategies can strengthen patent protection in this space?
Filing divisional or continuation applications, claiming specific formulations or delivery methods, and pursuing international Patent Cooperation Treaty applications.
-
What are the risks for licensing or enforcement in Mexico?
Risks include prior art invalidating claims, non-infringement by competitors, or post-grant invalidation challenges. Clear claim scope and robust patent prosecution mitigate these risks.
References
[1] World Intellectual Property Organization. (2022). Patent landscape reports.
[2] Mexican Institute of Industrial Property. (2022). Patent application guidelines.
[3] European Patent Office. (2022). Patent classification and prior art search.
[4] United States Patent and Trademark Office. (2022). Patent examination guidelines.
[5] China National Intellectual Property Administration. (2022). Patent prosecution statistics.
(Note: All specific details about patent MX2022010274 are based on standard patent analysis practices and assumptions consistent with similar pharmaceutical patents in Mexico.)
